Showing results (221-230 of 771) with videos related to
Sort By:
Pageof 78
Journal of Drugs in Dermatology : JDD|March 17, 2017
Regression Analysis of Local Skin Reactions to Predict Clearance of Actinic Keratosis on the Face in Patients Treated With Ingenol Mebutate Gel: Experience from Randomized Controlled TrialsShelbi Jim On, Kim Mark Knudsen, Torsten Skov, et al.The Journal of Investigative Dermatology|August 20, 2003
Topical calcitriol is degraded by ultraviolet lightMark Lebwohl, John Quijije, Jean Gilliard, et al.Journal of Drugs in Dermatology : JDD|October 6, 2023
Successful Treatment of Lichen Planus With Oral UpadacitinibMelissa P Zundell, Joshua Kaminetsky, Mark Lebwohl, et al.Cutis|August 1, 2008
A single-center, double-blind, randomized trial of the atrophogenic effects of fluocinonide cream 0.1% versus clobetasol propionate cream 0.05% in participants with corticosteroid-responsive dermatosesAnnemarie Uliasz, Joshua Zeichner, Jennifer Soung, et al.Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|May 10, 2006
Chemoprevention of nonmelanoma skin cancer with systemic retinoids: practical dosing and management of adverse effectsClark C Otley, Thomas Stasko, Whitney D Tope, et al.Journal of Drugs in Dermatology : JDD|November 5, 2011
A review of the chemopreventative effects of oral retinoids for internal neoplasmsTina Bhutani, John KooDermatologic Therapy|April 27, 2010
Psoriasis: depression, anxiety, smoking, and drinking habitsJennifer Hayes, John KooJournal of Drugs in Dermatology : JDD|November 24, 2005
Evidence based or theoretical concern? Pseudotumor cerebri and depression as acitretin side effectsJohn Starling, John KooThe Journal of Dermatological Treatment|April 18, 2015
Evidence-based adverse effects of biologic agents in the treatment of moderate-to-severe psoriasis: Providing clarity to an opaque topicEric Sorenson, John KooThe Journal of Dermatological Treatment|June 8, 2010
Paradoxical worsening of psoriasis when switching from etanercept to adalimumab: a case seriesTina Bhutani, John KooPageof 78